Clinical Trial

CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms

Name: CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms — clinical trial record (NCT07416682)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a single arm study to evaluate the safety and efficacy of CAR BCMA-CD70 CAR-T cell therapy for high-risk plasma cell neoplasms.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-14

Trial Details

NCT Number	NCT07416682
Lead Sponsor	Affiliated Hospital to Academy of Military Medical Sciences
Conditions	High-risk Plasma Cell Neoplasms
Enrollment	20 participants
Start Date	2026-04-14
Primary Completion	2027-01-30 (estimated)
Study Completion	2028-01-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-13